fadrozole has been researched along with Local Neoplasm Recurrence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, I; Ikeda, T; Ohashi, Y; Sasaki, Y; Suwa, T; Tabei, T; Takatsuka, Y; Toi, M; Tominaga, T | 1 |
| Abe, O; Koyama, H; Nomura, Y; Oohashi, Y; Takashima, S; Wada, T | 1 |
| Abe, O; Abe, R; Aoyama, H; Asaishi, K; Enomoto, K; Kajiwara, T; Ohasi, Y; Tominaga, T; Yoshida, M | 1 |
| Akiyama, H; Hisamatsu, K; Iwamori, S; Minami, K; Ota, K; Tanabe, K | 1 |
| Ando, T; Ide, M; Kobayashi, M; Kuwano, H; Mochida, Y; Ohno, Y; Sekihara, M; Tsuzuki, Y; Uchida, N; Yoshikawa, M | 1 |
| Kimura, M; Nomura, Y; Ohashi, Y; Takashima, S; Toge, T; Tominaga, T | 1 |
| Kurebayashi, J; Sonoo, H | 1 |
1 review(s) available for fadrozole and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[Endocrine therapy for advanced or recurrent breast cancer].
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Fadrozole; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Neoplasm Recurrence, Local; Tamoxifen; Toremifene | 2001 |
4 trial(s) available for fadrozole and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.
Topics: Administration, Oral; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrone; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Safety; Survival Rate; Triazoles | 2003 |
[Late phase II study of CGS16949A, a new aromatase inhibitor--a multicentral cooperative study (Western Japan Group)].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Estradiol; Estrone; Fadrozole; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Postmenopause | 1994 |
[Clinical evaluation of CGS16949A in advanced or recurrent breast cancer--a multi-institutional late phase II clinical trial].
Topics: Administration, Oral; Adult; Aged; Anorexia; Breast Neoplasms; Drug Administration Schedule; Fadrozole; Female; Humans; Middle Aged; Nausea; Neoplasm Recurrence, Local; Postmenopause | 1994 |
[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen].
Topics: Aged; Aldosterone; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Fadrozole; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Postmenopause; Tamoxifen | 2000 |
2 other study(ies) available for fadrozole and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[A case of a premenopausal woman with advanced breast cancer treated with aromatization inhibition in combination with luteinizing hormone-releasing hormone agonist].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Neoplasm Recurrence, Local; Pleural Neoplasms; Premenopause | 1997 |
Malignant proliferating trichilemmal tumor in the skin over the breast: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Fadrozole; Female; Fluorouracil; Hair Diseases; Hair Follicle; Humans; Lymphatic Metastasis; Mastectomy, Radical; Mitomycin; Neoplasm Recurrence, Local; Skin Neoplasms | 2000 |